PHAT FY 2024 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55M+8001.5% YoY

Gross Profit

$47M85.6% margin

Operating Income

-$277M-502.2% margin

Net Income

-$334M-605.1% margin

EPS (Diluted)

$-5.29

Cash Flow

Operating Cash Flow

-$267M

Free Cash Flow

-$267M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$378M

Total Liabilities

$632M

Stockholders' Equity

-$254M

Cash & Equivalents

$297M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$682,000	+8001.5%
Gross Profit	$47M	$515,000	+9080.4%
Operating Income	-$277M	-$167M	-65.8%
Net Income	-$334M	-$202M	-65.8%